“fidelity-investments” Archives

in
Entry Author Date Location
Generation Bio Leads a Trio of Biotech Companies Aiming for the Nasdaq 05/22/20 National
Boston Tech Watch: Huawei, Care.com, Cambridge Blockchain & PayPal 04/05/19 Boston
Boston Tech Watch: CoinMetrics, Bedrock Data, Modulate & Jobcase 03/01/19 Boston
Database Automation Software Maker Datical Adds $10M for New Hires 02/28/19 Texas
Coinbase Backs Flipside Crypto Amid “Healthy” Currency Selloff 11/29/18 Boston
Boston Tech Watch: Scooter Regs, Threat Stack, iRobot, Teikametrics 10/26/18 Boston
Fidelity CEO Hints at Crypto Products as Sector Aims for Mainstream 09/14/18 Boston
Fidelity Vets Launch Castle Island Ventures, a $30M Blockchain Fund 08/15/18 Boston
Banks & Insurers Seek Out Startups in New MassChallenge Accelerator 06/04/18 Boston
Buoy Snags $6.7M for Chatbot, as A.I. Pushes Further Into Healthcare 08/09/17 Boston
Boston Startup Exit Data Show Region’s Shift From Tech to Healthcare 04/04/17 Boston
First Trial Underway, Jounce Preps IPO To Fund Immuno-Oncology Work 01/03/17 Boston
Celldex, Aiming For More Cancer Drug Combos, Pays $62.5M For Kolltan 11/01/16 New York
After Failed Schizophrenia Trial, Forum Pharma To Shutter This Week 06/27/16 Boston
Academia, Industry Scramble to Fill Cybersecurity Talent Pipeline 06/20/16 Boston
Localytics Pushes Toward Profits After Layoffs and Market Slowdown 05/23/16 Boston
Boston Startups Combat New Threats in Cybersecurity “War Zone” 04/21/16 Boston
Texas Roundup: Datical, CPRIT, Pivot3, SonarMed, TMCx, & CareAline 02/01/16 Texas
Austin’s Datical Gets VC Cash to Manage Databases for App Updates 01/28/16 Texas
Enterprise Tech Strikes Back: Photos and Takeaways 12/04/15 Boston
Dunsire, Forum Pharma Look Beyond Fidelity For Big Alzheimer’s Push 04/22/15 Boston
Mobiquity Acquires European Mobile Consultant Morgan Clark 03/31/15 Boston
With $24M and Pharma Backing, Ex Epizyme Prez Aims to “Raze” Tumors 10/14/14 Boston
SVB Invests $3M in Startup Institute as Financial Firms Back Techies 09/16/14 Boston
Xconomy Launches in Raleigh-Durham—10th Cluster in Our Network 07/24/14 National
Sage, Despite Industry-Wide Pullback, Scores $90M in Upsized IPO 07/17/14 Boston
Zafgen Hauls In $96M in Upsized IPO 06/18/14 Boston
Sage Therapeutics Readies IPO Pitch to Develop CNS Drugs 06/18/14 Boston
Zafgen Lines Up $86M IPO to Bankroll Obesity Drug Push 04/20/14 Boston
Concert Pharma Heads to Nasdaq, Prices IPO at $14 Per Share 02/13/14 Boston
Page 1 of 2 next page »